Yu, D.; Wagner, S.; Schütz, M.; Jeon, Y.; Seo, M.; Kim, J.; Brückner, N.; Kicuntod, J.; Tillmanns, J.; Wangen, C.;
et al. An Antiherpesviral Host-Directed Strategy Based on CDK7 Covalently Binding Drugs: Target-Selective, Picomolar-Dose, Cross-Virus Reactivity. Pharmaceutics 2024, 16, 158.
https://doi.org/10.3390/pharmaceutics16020158
AMA Style
Yu D, Wagner S, Schütz M, Jeon Y, Seo M, Kim J, Brückner N, Kicuntod J, Tillmanns J, Wangen C,
et al. An Antiherpesviral Host-Directed Strategy Based on CDK7 Covalently Binding Drugs: Target-Selective, Picomolar-Dose, Cross-Virus Reactivity. Pharmaceutics. 2024; 16(2):158.
https://doi.org/10.3390/pharmaceutics16020158
Chicago/Turabian Style
Yu, DongHoon, Sabrina Wagner, Martin Schütz, Yeejin Jeon, Mooyoung Seo, Jaeseung Kim, Nadine Brückner, Jintawee Kicuntod, Julia Tillmanns, Christina Wangen,
and et al. 2024. "An Antiherpesviral Host-Directed Strategy Based on CDK7 Covalently Binding Drugs: Target-Selective, Picomolar-Dose, Cross-Virus Reactivity" Pharmaceutics 16, no. 2: 158.
https://doi.org/10.3390/pharmaceutics16020158
APA Style
Yu, D., Wagner, S., Schütz, M., Jeon, Y., Seo, M., Kim, J., Brückner, N., Kicuntod, J., Tillmanns, J., Wangen, C., Hahn, F., Kaufer, B. B., Neipel, F., Eickhoff, J., Klebl, B., Nam, K., & Marschall, M.
(2024). An Antiherpesviral Host-Directed Strategy Based on CDK7 Covalently Binding Drugs: Target-Selective, Picomolar-Dose, Cross-Virus Reactivity. Pharmaceutics, 16(2), 158.
https://doi.org/10.3390/pharmaceutics16020158